Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

44.40INR
19 Jan 2018
Change (% chg)

Rs0.45 (+1.02%)
Prev Close
Rs43.95
Open
Rs44.25
Day's High
Rs44.90
Day's Low
Rs43.10
Volume
3,574,926
Avg. Vol
5,160,705
52-wk High
Rs58.25
52-wk Low
Rs34.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 2,738.09 0.230
Jun 2,210.56 0.333
FY 2017 Mar '17 1,847.49 -0.079
Dec 2,152.39 0.276
Sep 1,804.26 0.017
Jun 1,867.47 0.110
FY 2016 Mar '16 2,102.31 -0.140
Dec 2,174.07 0.440
Sep 2,555.30 0.852
Jun 2,101.59 0.769
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-18 2 10,224.00 10,296.00 10,152.00 10,214.00
Year Ending Mar-19 2 11,892.50 12,152.00 11,633.00 --
Earnings (per share)
Year Ending Mar-18 2 1.50 1.70 1.30 2.65
Year Ending Mar-19 2 2.70 2.90 2.50 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 88.58 31.10 32.90
P/E High - Last 5 Yrs. 202.74 40.98 46.03
P/E Low - Last 5 Yrs. 3.32 23.80 24.39
Beta 1.92 0.90 0.89
Price to Sales (TTM) 2.45 3.98 5.45
Price to Book (MRQ) -- 4.82 5.38
Price to Tangible Book (MRQ) -- 5.57 6.89
Price to Cash Flow (TTM) 34.23 23.02 23.43
% Owned Institutions -- 1.23 2.16

Dividends

  Company industry sector
Dividend Yield 0.10 1.56 1.50
Dividend Yield - 5 Year Avg 0.21 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) 12.73 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 18.37 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago -7.87 4.69 5.44
Sales - 5 Yr. Growth Rate 16.63 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 202.90 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago -57.13 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate 39.36 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.88 2.97
LT Debt to Equity (MRQ) -- 9.81 12.10
Total Debt to Equity (MRQ) -- 13.80 16.38
Interest Coverage (TTM) 8.43 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.70 55.13 54.76
Gross Margin - 5 Yr. Avg. 38.62 52.41 52.45
EBITD Margin (TTM) 8.13 -- --
EBITD - 5 Yr. Avg 14.77 18.54 15.33
Operating Margin (TTM) 4.05 14.40 7.60
Operating Margin - 5 Yr. Avg. 11.77 14.46 10.79
Pre-Tax Margin (TTM) 4.12 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. 11.58 14.77 11.19
Net Profit Margin (TTM) 3.06 11.09 4.70
Net Profit Margin - 5 Yr. Avg. 9.34 11.11 7.50
Effective Tax Rate (TTM) 25.61 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. 19.36 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,178,110 948,195,516 855,725,045
Net Income/Employee (TTM) 342,558 111,561,295 100,665,187
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.34
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.41 10.97
Return on Assets - 5 Yr. Avg. 11.52 12.98 12.39
Return on Investment (TTM) -- 14.84 14.40
Return on Investment - 5 Yr. Avg. 26.35 16.97 16.20
Return on Equity (TTM) -- 16.32 16.09
Return on Equity - 5 Yr. Avg. 27.24 18.05 17.53
  1 Year 3 Year 5 Year
Sales % -14.12 6.79 16.63
EPS (TTM) % -87.88 -50.08 --
Dividend % -58.33 -20.63 --
Note: Units in Millions of US Dollars

Performance for Marksans Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 21.88 21.40 99 25
13 Week 11.66 10.06 99 36
26 Week -8.15 -14.23 99 31
52 Week -14.00 -24.03 99 12
YTD 20.20 0.60 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.47%
# of Holders: 17
Total Shares Held: 26,482,283
3 Mo. Net Change: -755,022
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 2
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.